{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:38:03Z","timestamp":1787060283613,"version":"build-2736575974"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI181746"],"award-info":[{"award-number":["R01AI181746"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R44AI152954"],"award-info":[{"award-number":["R44AI152954"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21AI144891"],"award-info":[{"award-number":["R21AI144891"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI154542"],"award-info":[{"award-number":["R01AI154542"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"United States Department of Defense | United States Army | Army Medical Command | Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["W81XWH-20-1-0913"],"award-info":[{"award-number":["W81XWH-20-1-0913"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:italic>Borrelia burgdorferi<\/jats:italic>\n                    (\n                    <jats:italic>Bb<\/jats:italic>\n                    ) causes Lyme disease (LD), one of the most common vector-borne diseases in the Northern Hemisphere. Here, we solve the crystal structure of a mutated\n                    <jats:italic>Bb<\/jats:italic>\n                    vaccine antigen, CspZ-YA that lacks the ability to bind to host complement factor H (FH). We generate point mutants of CspZ-YA and identify CspZ-YA\n                    <jats:sub>I183Y<\/jats:sub>\n                    and CspZ-YA\n                    <jats:sub>C187S<\/jats:sub>\n                    to trigger more robust bactericidal responses. Compared to CspZ-YA, these CspZ-YA mutants require a lower immunization frequency to protect mice from LD-associated inflammation and bacterial colonization. Antigenicity of wild-type and mutant CspZ-YA proteins are similar, as measured using sera from infected people or immunized female mice. Structural comparison of CspZ-YA with CspZ-YA\n                    <jats:sub>I183Y<\/jats:sub>\n                    and CspZ-YA\n                    <jats:sub>C187S<\/jats:sub>\n                    shows enhanced interactions of two helices adjacent to the FH-binding sites in the mutants, consistent with their elevated thermostability. In line with these findings, protective CspZ-YA monoclonal antibodies show increased binding to CspZ-YA at a physiological temperature (37\u2009\u00b0C). In summary, this proof-of-concept study applies structural vaccinology to enhance intramolecular interactions for the long-term stability of a\n                    <jats:italic>Bb<\/jats:italic>\n                    antigen while maintaining its protective epitopes, thus promoting LD vaccine development.\n                  <\/jats:p>","DOI":"10.1038\/s41467-025-58182-x","type":"journal-article","created":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T19:01:50Z","timestamp":1743966110000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Mechanistic insights into the structure-based design of a CspZ-targeting Lyme disease vaccine"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0757-7462","authenticated-orcid":false,"given":"Kalvis","family":"Brangulis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Malfetano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley L.","family":"Marcinkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6814-3626","authenticated-orcid":false,"given":"Alan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jungsoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuyun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuli","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9455-7683","authenticated-orcid":false,"given":"Ulrich","family":"Strych","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagnija","family":"Tupina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inara","family":"Akopjana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8429-0476","authenticated-orcid":false,"given":"Maria-Elena","family":"Bottazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7504-4628","authenticated-orcid":false,"given":"Utpal","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Lin","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0542-1598","authenticated-orcid":false,"given":"Wen-Hsiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5240-2031","authenticated-orcid":false,"given":"Yi-Pin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"key":"58182_CR1","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1128\/CMR.14.4.872-908.2001","volume":"14","author":"PH Dennehy","year":"2001","unstructured":"Dennehy, P. H. Active immunization in the United States: developments over the past decade. Clin. Microbiol. Rev. 14, 872\u2013908 (2001).","journal-title":"Clin. Microbiol. Rev."},{"key":"58182_CR2","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1517\/14740338.2016.1167869","volume":"15","author":"N Principi","year":"2016","unstructured":"Principi, N. & Esposito, S. Adverse events following immunization: real causality and myths. Expert Opin. Drug Saf. 15, 825\u2013835 (2016).","journal-title":"Expert Opin. Drug Saf."},{"key":"58182_CR3","first-page":"S61","volume":"56","author":"SR Kimmel","year":"2007","unstructured":"Kimmel, S. R., Burns, I. T., Wolfe, R. M. & Zimmerman, R. K. Addressing immunization barriers, benefits, and risks. J. Fam. Pr. 56, S61\u2013S69 (2007).","journal-title":"J. Fam. Pr."},{"key":"58182_CR4","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrd818","volume":"1","author":"H Schellekens","year":"2002","unstructured":"Schellekens, H. Bioequivalence and the immunogenicity of biopharmaceuticals. Nat. Rev. Drug Discov. 1, 457\u2013462 (2002).","journal-title":"Nat. Rev. Drug Discov."},{"key":"58182_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-021-00417-1","volume":"6","author":"TM Caradonna","year":"2021","unstructured":"Caradonna, T. M. & Schmidt, A. G. Protein engineering strategies for rational immunogen design. NPJ Vaccines 6, 154 (2021).","journal-title":"NPJ Vaccines"},{"key":"58182_CR6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1146\/annurev-med-121217-094234","volume":"70","author":"BS Graham","year":"2019","unstructured":"Graham, B. S., Gilman, M. S. A. & McLellan, J. S. Structure-based vaccine antigen design. Annu. Rev. Med. 70, 91\u2013104 (2019).","journal-title":"Annu. Rev. Med."},{"key":"58182_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2022.102209","volume":"77","author":"PO Byrne","year":"2022","unstructured":"Byrne, P. O. & McLellan, J. S. Principles and practical applications of structure-based vaccine design. Curr. Opin. Immunol. 77, 102209 (2022).","journal-title":"Curr. Opin. Immunol."},{"key":"58182_CR8","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1126\/science.abd0826","volume":"369","author":"CL Hsieh","year":"2020","unstructured":"Hsieh, C. L. et al. Structure-based design of prefusion-stabilized SARS-CoV-2 spikes. Science 369, 1501\u20131505 (2020).","journal-title":"Science"},{"key":"58182_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45404-x","volume":"15","author":"CL Hsieh","year":"2024","unstructured":"Hsieh, C. L. et al. Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challenge. Nat. Commun. 15, 1553 (2024).","journal-title":"Nat. Commun."},{"key":"58182_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109929","volume":"37","author":"CL Hsieh","year":"2021","unstructured":"Hsieh, C. L. et al. Stabilized coronavirus spike stem elicits a broadly protective antibody. Cell Rep. 37, 109929 (2021).","journal-title":"Cell Rep."},{"key":"58182_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.sbi.2022.102385","volume":"74","author":"CL Hsieh","year":"2022","unstructured":"Hsieh, C. L. & McLellan, J. S. Protein engineering responses to the COVID-19 pandemic. Curr. Opin. Struct. Biol. 74, 102385 (2022).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"58182_CR12","doi-asserted-by":"publisher","first-page":"616","DOI":"10.3201\/eid2702.202731","volume":"27","author":"KJ Kugeler","year":"2021","unstructured":"Kugeler, K. J., Schwartz, A. M., Delorey, M. J., Mead, P. S. & Hinckley, A. F. Estimating the frequency of Lyme disease diagnoses, United States, 2010-2018. Emerg. Infect. Dis. 27, 616\u2013619 (2021).","journal-title":"Emerg. Infect. Dis."},{"key":"58182_CR13","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3201\/eid2702.202728","volume":"27","author":"AM Schwartz","year":"2021","unstructured":"Schwartz, A. M., Kugeler, K. J., Nelson, C. A., Marx, G. E. & Hinckley, A. F. Use of commercial claims data for evaluating trends in Lyme disease diagnoses, United States, 2010-2018. Emerg. Infect. Dis. 27, 499\u2013507 (2021).","journal-title":"Emerg. Infect. Dis."},{"key":"58182_CR14","doi-asserted-by":"publisher","first-page":"ITC65","DOI":"10.7326\/AITC201605030","volume":"164","author":"LT Hu","year":"2016","unstructured":"Hu, L. T. Lyme disease. Ann. Intern. Med. 164, ITC65\u2013ITC80 (2016).","journal-title":"Ann. Intern. Med."},{"key":"58182_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.90","volume":"2","author":"AC Steere","year":"2016","unstructured":"Steere, A. C. et al. Lyme borreliosis. Nat. Rev. Dis. Prim. 2, 16090 (2016).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"58182_CR16","first-page":"333","volume":"42","author":"JD Radolf","year":"2021","unstructured":"Radolf, J. D., Strle, K., Lemieux, J. E. & Strle, F. Lyme disease in humans. Curr. Issues Mol. Biol. 42, 333\u2013384 (2021).","journal-title":"Curr. Issues Mol. Biol."},{"key":"58182_CR17","doi-asserted-by":"crossref","unstructured":"Gomes-Solecki, M. et al. Protective immunity and new vaccines for Lyme disease. Clin. Infect. Dis. 70, 1768\u20131773 (2019).","DOI":"10.1093\/cid\/ciz872"},{"key":"58182_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-022-00429-5","volume":"7","author":"RJ Dattwyler","year":"2022","unstructured":"Dattwyler, R. J. & Gomes-Solecki, M. The year that shaped the outcome of the OspA vaccine for human Lyme disease. NPJ Vaccines 7, 10 (2022).","journal-title":"NPJ Vaccines"},{"key":"58182_CR19","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/S1473-3099(23)00210-4","volume":"23","author":"N Bezay","year":"2023","unstructured":"Bezay, N. et al. Safety and immunogenicity of a novel multivalent OspA-based vaccine candidate against Lyme borreliosis: a randomised, phase 1 study in healthy adults. Lancet Infect. Dis. 23, 1186\u20131196 (2023).","journal-title":"Lancet Infect. Dis."},{"key":"58182_CR20","unstructured":"Valneva and Pfizer report positive pediatric and adolescent phase 2 booster results for Lyme disease vaccine Ccandidate. (2023)."},{"key":"58182_CR21","unstructured":"Pfizer and Valneva complete recruitment for Phase 3 VALOR Trial for Lyme disease vaccine candidate, VLA15.) (2023)."},{"key":"58182_CR22","doi-asserted-by":"crossref","unstructured":"Bezay, N. et al. Optimisation of dose level and vaccination schedule for the VLA15 Lyme borreliosis vaccine candidate among healthy adults: two randomised, observer-blind, placebo-controlled, multicentre, phase 2 studies. Lancet Infect. Dis. 24, 1045\u20131058 (2024).","DOI":"10.1016\/S1473-3099(24)00175-0"},{"key":"58182_CR23","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.3389\/fmicb.2019.01923","volume":"10","author":"MJ Caimano","year":"2019","unstructured":"Caimano, M. J. et al. The RpoS gatekeeper in Borrelia burgdorferi: an invariant regulatory scheme that promotes spirochete persistence in reservoir hosts and niche diversity. Front. Microbiol. 10, 1923 (2019).","journal-title":"Front. Microbiol."},{"key":"58182_CR24","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1073\/pnas.98.2.670","volume":"98","author":"J Ohnishi","year":"2001","unstructured":"Ohnishi, J., Piesman, J. & de Silva, A. M. Antigenic and genetic heterogeneity of Borrelia burgdorferi populations transmitted by ticks. Proc. Natl Acad. Sci. USA 98, 670\u2013675 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"58182_CR25","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae467","volume":"11","author":"U Lundberg","year":"2024","unstructured":"Lundberg, U. et al. Preclinical evidence for the protective capacity of antibodies induced by Lyme vaccine candidate VLA15 in people. Open Forum Infect. Dis. 11, ofae467 (2024).","journal-title":"Open Forum Infect. Dis."},{"key":"58182_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-023-00802-y","volume":"9","author":"MC Gingerich","year":"2024","unstructured":"Gingerich, M. C. et al. Intranasal vaccine for Lyme disease provides protection against tick transmitted Borrelia burgdorferi beyond one year. NPJ Vaccines 9, 33 (2024).","journal-title":"NPJ Vaccines"},{"key":"58182_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-020-0183-8","volume":"5","author":"HD Kamp","year":"2020","unstructured":"Kamp, H. D. et al. Design of a broadly reactive Lyme disease vaccine. NPJ Vaccines 5, 33 (2020).","journal-title":"NPJ Vaccines"},{"key":"58182_CR28","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1111\/j.1365-2958.2006.05318.x","volume":"61","author":"K Hartmann","year":"2006","unstructured":"Hartmann, K. et al. Functional characterization of BbCRASP-2, a distinct outer membrane protein of Borrelia burgdorferi that binds host complement regulators factor H and FHL-1. Mol. Microbiol. 61, 1220\u20131236 (2006).","journal-title":"Mol. Microbiol."},{"key":"58182_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcimb.2020.00001","volume":"10","author":"YP Lin","year":"2020","unstructured":"Lin, Y. P., Frye, A. M., Nowak, T. A. & Kraiczy, P. New insights into CRASP-mediated complement evasion in the Lyme disease enzootic cycle. Front. Cell. Infect. Microbiol. 10, 1 (2020).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"58182_CR30","doi-asserted-by":"publisher","first-page":"e1011243","DOI":"10.1371\/journal.ppat.1011243","volume":"19","author":"JE Lemieux","year":"2023","unstructured":"Lemieux, J. E. et al. Whole genome sequencing of human Borrelia burgdorferi isolates reveals linked blocks of accessory genome elements located on plasmids and associated with human dissemination. PLoS Pathog. 19, e1011243 (2023).","journal-title":"PLoS Pathog."},{"key":"58182_CR31","doi-asserted-by":"publisher","first-page":"4396","DOI":"10.1128\/IAI.00393-09","volume":"77","author":"EA Rogers","year":"2009","unstructured":"Rogers, E. A., Abdunnur, S. V., McDowell, J. V. & Marconi, R. T. Comparative analysis of the properties and ligand binding characteristics of CspZ, a factor H binding protein, derived from Borrelia burgdorferi isolates of human origin. Infect. Immun. 77, 4396\u20134405 (2009).","journal-title":"Infect. Immun."},{"key":"58182_CR32","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1128\/CVI.00415-07","volume":"15","author":"P Kraiczy","year":"2008","unstructured":"Kraiczy, P. et al. Borrelia burgdorferi complement regulator-acquiring surface protein 2 (CspZ) as a serological marker of human Lyme disease. Clin. Vaccin. immunol. 15, 484\u2013491 (2008).","journal-title":"Clin. Vaccin. immunol."},{"key":"58182_CR33","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.ijmm.2007.10.002","volume":"298","author":"T Bykowski","year":"2008","unstructured":"Bykowski, T. et al. Borrelia burgdorferi complement regulator-acquiring surface proteins (BbCRASPs): Expression patterns during the mammal-tick infection cycle. Int. J. Med. Microbiol. 298, 249\u2013256 (2008).","journal-title":"Int. J. Med. Microbiol."},{"key":"58182_CR34","doi-asserted-by":"publisher","DOI":"10.1111\/cmi.12998","volume":"21","author":"AL Marcinkiewicz","year":"2019","unstructured":"Marcinkiewicz, A. L. et al. Blood treatment of Lyme borreliae demonstrates the mechanism of CspZ-mediated complement evasion to promote systemic infection in vertebrate hosts. Cell. Microbiol. 21, e12998 (2019).","journal-title":"Cell. Microbiol."},{"key":"58182_CR35","doi-asserted-by":"publisher","first-page":"34855","DOI":"10.1074\/jbc.M805844200","volume":"283","author":"C Siegel","year":"2008","unstructured":"Siegel, C. et al. Deciphering the ligand-binding sites in the Borrelia burgdorferi complement regulator-acquiring surface protein 2 required for interactions with the human immune regulators factor H and factor H-like protein 1. J. Biol. Chem. 283, 34855\u201334863 (2008).","journal-title":"J. Biol. Chem."},{"key":"58182_CR36","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3389\/fimmu.2018.00181","volume":"9","author":"AL Marcinkiewicz","year":"2018","unstructured":"Marcinkiewicz, A. L. et al. Eliminating factor H-binding activity of Borrelia burgdorferi CspZ combined with virus-like particle conjugation enhances its efficacy as a Lyme disease vaccine. Front. Immunol. 9, 181 (2018).","journal-title":"Front. Immunol."},{"key":"58182_CR37","doi-asserted-by":"crossref","unstructured":"Marcinkiewicz, A. L. et al. The factor H-binding site of CspZ as a protective target against multistrain, tick-transmitted Lyme disease. Infect. Immun. 88, e00956-19 (2020).","DOI":"10.1128\/IAI.00956-19"},{"key":"58182_CR38","doi-asserted-by":"publisher","DOI":"10.1128\/iai.00062-22","volume":"90","author":"YL Chen","year":"2022","unstructured":"Chen, Y. L. et al. CspZ FH-binding sites as epitopes promote antibody-mediated Lyme borreliae clearance. Infect. Immun. 90, e0006222 (2022).","journal-title":"Infect. Immun."},{"key":"58182_CR39","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1107\/S0907444911007281","volume":"67","author":"S McNicholas","year":"2011","unstructured":"McNicholas, S., Potterton, E., Wilson, K. S. & Noble, M. E. Presenting your structures: the CCP4mg molecular-graphics software. Acta Crystallogr. Sect. D Biol. Crystallogr. 67, 386\u2013394 (2011).","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"58182_CR40","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2301549120","volume":"120","author":"AL Marcinkiewicz","year":"2023","unstructured":"Marcinkiewicz, A. L. et al. Structural evolution of an immune evasion determinant shapes pathogen host tropism. Proc. Natl Acad. Sci. USA 120, e2301549120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"58182_CR41","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1080\/21645515.2016.1242540","volume":"13","author":"CA Seid","year":"2017","unstructured":"Seid, C. A. et al. Cysteine mutagenesis improves the production without abrogating antigenicity of a recombinant protein vaccine candidate for human chagas disease. Hum. Vaccin Immunother. 13, 621\u2013633 (2017).","journal-title":"Hum. Vaccin Immunother."},{"key":"58182_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2021.129893","volume":"1865","author":"WH Chen","year":"2021","unstructured":"Chen, W. H. et al. Genetic modification to design a stable yeast-expressed recombinant SARS-CoV-2 receptor binding domain as a COVID-19 vaccine candidate. Biochim. Biophys. Acta Gen. Subj. 1865, 129893 (2021).","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"58182_CR43","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1016\/j.ajpath.2011.02.018","volume":"178","author":"K Strle","year":"2011","unstructured":"Strle, K., Jones, K. L., Drouin, E. E., Li, X. & Steere, A. C. Borrelia burgdorferi RST1 (OspC type A) genotype is associated with greater inflammation and more severe Lyme disease. Am. J. Pathol. 178, 2726\u20132739 (2011).","journal-title":"Am. J. Pathol."},{"key":"58182_CR44","doi-asserted-by":"publisher","first-page":"3990","DOI":"10.1128\/JCM.37.12.3990-3996.1999","volume":"37","author":"FT Liang","year":"1999","unstructured":"Liang, F. T. et al. Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE. J. Clin. Microbiol. 37, 3990\u20133996 (1999).","journal-title":"J. Clin. Microbiol."},{"key":"58182_CR45","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1128\/iai.60.3.773-777.1992","volume":"60","author":"E Fikrig","year":"1992","unstructured":"Fikrig, E., Barthold, S. W., Kantor, F. S. & Flavell, R. A. Long-term protection of mice from Lyme disease by vaccination with OspA. Infect. Immun. 60, 773\u2013777 (1992).","journal-title":"Infect. Immun."},{"key":"58182_CR46","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583\u2013589 (2021).","journal-title":"Nature"},{"key":"58182_CR47","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1016\/j.bpj.2010.01.014","volume":"98","author":"G Scarabelli","year":"2010","unstructured":"Scarabelli, G., Morra, G. & Colombo, G. Predicting interaction sites from the energetics of isolated proteins: a new approach to epitope mapping. Biophys. J. 98, 1966\u20131975 (2010).","journal-title":"Biophys. J."},{"key":"58182_CR48","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s42003-020-01153-3","volume":"3","author":"SF Ausar","year":"2020","unstructured":"Ausar, S. F. et al. Genetically detoxified pertussis toxin displays near identical structure to its wild-type and exhibits robust immunogenicity. Commun. Biol. 3, 427 (2020).","journal-title":"Commun. Biol."},{"key":"58182_CR49","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1080\/21645515.2015.1036207","volume":"11","author":"CA Seid","year":"2015","unstructured":"Seid, C. A. et al. Expression, purification, and characterization of the Necator americanus aspartic protease-1 (Na-APR-1 (M74)) antigen, a component of the bivalent human hookworm vaccine. Hum. Vaccin Immunother. 11, 1474\u20131488 (2015).","journal-title":"Hum. Vaccin Immunother."},{"key":"58182_CR50","doi-asserted-by":"publisher","first-page":"5103","DOI":"10.1016\/j.vaccine.2022.07.011","volume":"40","author":"MJ Chang","year":"2022","unstructured":"Chang, M. J. et al. Genetically detoxified tetanus toxin as a vaccine and conjugate carrier protein. Vaccine 40, 5103\u20135113 (2022).","journal-title":"Vaccine"},{"key":"58182_CR51","doi-asserted-by":"crossref","unstructured":"Chen, W. H., Strych, U., Bottazzi, M. E. & Lin, Y. P. Past, present, and future of Lyme disease vaccines: antigen engineering approaches and mechanistic insights. Expert Rev. Vaccines 21, 1405\u20131417 (2022).","DOI":"10.1080\/14760584.2022.2102484"},{"key":"58182_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2023.168113","volume":"435","author":"WC Koff","year":"2023","unstructured":"Koff, W. C., Rappuoli, R. & Plotkin, S. A. Historical advances in structural and molecular biology and how they impacted vaccine development. J. Mol. Biol. 435, 168113 (2023).","journal-title":"J. Mol. Biol."},{"key":"58182_CR53","doi-asserted-by":"publisher","first-page":"5171","DOI":"10.1016\/j.cell.2024.07.021","volume":"187","author":"R Rappuoli","year":"2024","unstructured":"Rappuoli, R., Alter, G. & Pulendran, B. Transforming vaccinology. Cell 187, 5171\u20135194 (2024).","journal-title":"Cell"},{"key":"58182_CR54","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1126\/science.1243283","volume":"342","author":"JS McLellan","year":"2013","unstructured":"McLellan, J. S. et al. Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus. Science 342, 592\u2013598 (2013).","journal-title":"Science"},{"key":"58182_CR55","doi-asserted-by":"publisher","first-page":"9888","DOI":"10.1128\/JVI.76.19.9888-9899.2002","volume":"76","author":"SH Xiang","year":"2002","unstructured":"Xiang, S. H. et al. Mutagenic stabilization and\/or disruption of a CD4-bound state reveals distinct conformations of the human immunodeficiency virus type 1 gp120 envelope glycoprotein. J. Virol. 76, 9888\u20139899 (2002).","journal-title":"J. Virol."},{"key":"58182_CR56","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1126\/science.1553543","volume":"255","author":"AE Eriksson","year":"1992","unstructured":"Eriksson, A. E. et al. Response of a protein structure to cavity-creating mutations and its relation to the hydrophobic effect. Science 255, 178\u2013183 (1992).","journal-title":"Science"},{"key":"58182_CR57","doi-asserted-by":"publisher","first-page":"5910","DOI":"10.1073\/pnas.1605363113","volume":"113","author":"T Liu","year":"2016","unstructured":"Liu, T. et al. Enhancing protein stability with extended disulfide bonds. Proc. Natl Acad. Sci. USA 113, 5910\u20135915 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"58182_CR58","doi-asserted-by":"publisher","first-page":"11937","DOI":"10.1073\/pnas.0904191106","volume":"106","author":"N Chennamsetty","year":"2009","unstructured":"Chennamsetty, N., Voynov, V., Kayser, V., Helk, B. & Trout, B. L. Design of therapeutic proteins with enhanced stability. Proc. Natl Acad. Sci. USA 106, 11937\u201311942 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"58182_CR59","doi-asserted-by":"crossref","unstructured":"Brangulis, K. et al. CspZ variant-specific interaction with Factor H incorporates a metal site to support Lyme borreliae complement evasion. J. Biol. Chem. 301, 108083 (2024).","DOI":"10.1016\/j.jbc.2024.108083"},{"key":"58182_CR60","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/jps.10296","volume":"92","author":"DT Brandau","year":"2003","unstructured":"Brandau, D. T., Jones, L. S., Wiethoff, C. M., Rexroad, J. & Middaugh, C. R. Thermal stability of vaccines. J. Pharm. Sci. 92, 218\u2013231 (2003).","journal-title":"J. Pharm. Sci."},{"key":"58182_CR61","doi-asserted-by":"publisher","first-page":"e1007106","DOI":"10.1371\/journal.ppat.1007106","volume":"14","author":"T Hart","year":"2018","unstructured":"Hart, T. et al. Polymorphic factor H-binding activity of CspA protects Lyme borreliae from the host complement in feeding ticks to facilitate tick-to-host transmission. PLoS Pathog. 14, e1007106 (2018).","journal-title":"PLoS Pathog."},{"key":"58182_CR62","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1172\/JCI110998","volume":"72","author":"AG Barbour","year":"1983","unstructured":"Barbour, A. G., Burgdorfer, W., Grunwaldt, E. & Steere, A. C. Antibodies of patients with Lyme disease to components of the Ixodes dammini spirochete. J. Clin. Investig. 72, 504\u2013515 (1983).","journal-title":"J. Clin. Investig."},{"key":"58182_CR63","doi-asserted-by":"publisher","first-page":"13865","DOI":"10.1073\/pnas.97.25.13865","volume":"97","author":"JE Purser","year":"2000","unstructured":"Purser, J. E. & Norris, S. J. Correlation between plasmid content and infectivity in Borrelia burgdorferi. Proc. Natl Acad. Sci. USA 97, 13865\u201313870 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"58182_CR64","doi-asserted-by":"publisher","first-page":"703","DOI":"10.15585\/mmwr.mm6832a4","volume":"68","author":"P Mead","year":"2019","unstructured":"Mead, P., Petersen, J. & Hinckley, A. Updated CDC recommendation for serologic diagnosis of Lyme disease. MMWR Morb. Mortal Wkly. Rep. 68, 703 (2019).","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"key":"58182_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.129295","volume":"259","author":"YL Chen","year":"2024","unstructured":"Chen, Y. L. et al. Biophysical and biochemical characterization of a recombinant Lyme disease vaccine antigen, CspZ-YA. Int. J. Biol. Macromol. 259, 129295 (2024).","journal-title":"Int. J. Biol. Macromol."},{"key":"58182_CR66","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1128\/iai.61.1.81-90.1993","volume":"61","author":"LF Erdile","year":"1993","unstructured":"Erdile, L. F. et al. Role of attached lipid in immunogenicity of Borrelia burgdorferi OspA. Infect. Immun. 61, 81\u201390 (1993).","journal-title":"Infect. Immun."},{"key":"58182_CR67","doi-asserted-by":"crossref","unstructured":"Nayak, A. et al. Broadly protective multivalent OspA vaccine against Lyme borreliosis, developed based on surface shaping of the C-terminal fragment. Infect. Immun. 88, e00917-19 (2020).","DOI":"10.1128\/IAI.00917-19"},{"key":"58182_CR68","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1111\/febs.12808","volume":"281","author":"K Brangulis","year":"2014","unstructured":"Brangulis, K. et al. Structural characterization of CspZ, a complement regulator factor H and FHL-1 binding protein from Borrelia burgdorferi. FEBS J. 281, 2613\u20132622 (2014).","journal-title":"FEBS J."},{"key":"58182_CR69","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.bbapap.2005.06.005","volume":"1751","author":"SM Kelly","year":"2005","unstructured":"Kelly, S. M., Jess, T. J. & Price, N. C. How to study proteins by circular dichroism. Biochim. Biophys. Acta 1751, 119\u2013139 (2005).","journal-title":"Biochim. Biophys. Acta"},{"key":"58182_CR70","doi-asserted-by":"publisher","first-page":"3010e","DOI":"10.1371\/journal.pone.0003010","volume":"3","author":"AS Coleman","year":"2008","unstructured":"Coleman, A. S. et al. Borrelia burgdorferi complement regulator-acquiring surface protein 2 does not contribute to complement resistance or host infectivity. PLoS ONE 3, 3010e (2008).","journal-title":"PLoS ONE"},{"key":"58182_CR71","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1128\/IAI.69.5.3224-3231.2001","volume":"69","author":"FT Liang","year":"2001","unstructured":"Liang, F. T., Bowers, L. C. & Philipp, M. T. C-terminal invariable domain of VlsE is immunodominant but its antigenicity is scarcely conserved among strains of Lyme disease spirochetes. Infect. Immun. 69, 3224\u20133231 (2001).","journal-title":"Infect. Immun."},{"key":"58182_CR72","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1107\/S0909049512006395","volume":"19","author":"U Mueller","year":"2012","unstructured":"Mueller, U. et al. Facilities for macromolecular crystallography at the Helmholtz-Zentrum Berlin. J. Synchrotron Radiat. 19, 442\u2013449 (2012).","journal-title":"J. Synchrotron Radiat."},{"key":"58182_CR73","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1107\/S090744491003982X","volume":"67","author":"PR Evans","year":"2011","unstructured":"Evans, P. R. An introduction to data reduction: space-group determination, scaling and intensity statistics. Acta Crystallogr. Sect. D Biol. Crystallogr. 67, 282\u2013292 (2011).","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"58182_CR74","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1107\/S0907444910045749","volume":"67","author":"MD Winn","year":"2011","unstructured":"Winn, M. D. et al. Overview of the CCP4 suite and current developments. Acta Crystallogr. Sect. D Biol. Crystallogr. 67, 235\u2013242 (2011).","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"58182_CR75","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"AJ McCoy","year":"2007","unstructured":"McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658\u2013674 (2007).","journal-title":"J. Appl. Crystallogr."},{"key":"58182_CR76","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1107\/S0907444906022116","volume":"62","author":"K Cowtan","year":"2006","unstructured":"Cowtan, K. The Buccaneer software for automated model building. 1. Tracing protein chains. Acta Crystallogr. Sect. D Biol. Crystallogr. 62, 1002\u20131011 (2006).","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"58182_CR77","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. Sect. D Biol. Crystallogr. 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"58182_CR78","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1107\/S0907444996012255","volume":"53","author":"GN Murshudov","year":"1997","unstructured":"Murshudov, G. N., Vagin, A. A. & Dodson, E. J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. Sect. D Biol. Crystallogr. 53, 240\u2013255 (1997).","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"58182_CR79","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ymeth.2011.07.005","volume":"55","author":"PD Adams","year":"2011","unstructured":"Adams, P. D. et al. The Phenix software for automated determination of macromolecular structures. Methods 55, 94\u2013106 (2011).","journal-title":"Methods"},{"key":"58182_CR80","doi-asserted-by":"publisher","first-page":"e0296127","DOI":"10.1371\/journal.pone.0296127","volume":"19","author":"K Brangulis","year":"2024","unstructured":"Brangulis, K. et al. Members of the paralogous gene family 12 from the Lyme disease agent Borrelia burgdorferi are non-specific DNA-binding proteins. PLoS ONE 19, e0296127 (2024).","journal-title":"PLoS ONE"},{"key":"58182_CR81","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1-2","author":"MJ Abraham","year":"2015","unstructured":"Abraham, M. J. et al. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1-2, 19\u201325 (2015).","journal-title":"SoftwareX"},{"key":"58182_CR82","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1021\/ct300400x","volume":"8","author":"RB Best","year":"2012","unstructured":"Best, R. B. et al. Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone phi, psi and side-chain chi(1) and chi(2) dihedral angles. J. Chem. Theory Comput. 8, 3257\u20133273 (2012).","journal-title":"J. Chem. Theory Comput."},{"key":"58182_CR83","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","volume":"79","author":"WL Jorgensen","year":"1983","unstructured":"Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W. & Klein, M. L. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79, 926\u2013935 (1983).","journal-title":"J. Chem. Phys."},{"key":"58182_CR84","doi-asserted-by":"publisher","first-page":"10089","DOI":"10.1063\/1.464397","volume":"98","author":"T Darden","year":"1993","unstructured":"Darden, T., York, D. & Pedersen, L. Particle mesh Ewald: an N\u22c5log(N) method for Ewald sums in large systems. J. Chem. Phys. 98, 10089\u201310092 (1993).","journal-title":"J. Chem. Phys."},{"key":"58182_CR85","doi-asserted-by":"crossref","unstructured":"Hess, B., Bekker, H., Berendsen, H. J. C. & Fraaije, J. G. E. M. LINCS: a linear constraint solver for molecular simulations. J. Comput. Chem. 18, 1463\u20131472 (1998).","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.3.CO;2-L"},{"key":"58182_CR86","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey, W., Dalke, A. & Schulten, K. VMD: visual molecular dynamics. J. Mol. Graph. 14, 33\u201338 (1996).","journal-title":"J. Mol. Graph."},{"key":"58182_CR87","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.chom.2011.06.010","volume":"10","author":"TJ Schuijt","year":"2011","unstructured":"Schuijt, T. J. et al. A tick mannose-binding lectin inhibitor interferes with the vertebrate complement cascade to enhance transmission of the lyme disease agent. Cell Host Microbe 10, 136\u2013146 (2011).","journal-title":"Cell Host Microbe"},{"key":"58182_CR88","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1093\/biomet\/93.3.491","volume":"93","author":"Y Benjamini","year":"2006","unstructured":"Benjamini, Y., Krieger, A. M. & Yekutieli, D. Adaptive linear step-up procedures that control the false discovery rate. Biometrika 93, 491\u2013507 (2006).","journal-title":"Biometrika"},{"key":"58182_CR89","unstructured":"Fisher R. A. Statistical Methods for Research Workers 5th edn. (Oliver&Boyd, 1934)."},{"key":"58182_CR90","doi-asserted-by":"crossref","unstructured":"Spearman C. The proof and measurement of association between two things. Am. J. Psychol. 15, 72\u2013101 (1904).","DOI":"10.2307\/1412159"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58182-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58182-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58182-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T19:01:53Z","timestamp":1743966113000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58182-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["58182"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-58182-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,7]]},"assertion":[{"value":"12 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Y.L. is the inventor of US patent application no. US11771750B2 (\u201cComposition and method for generating immunity to\n                      Borrelia burgdorferi\n                      \u201d). The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2898"}}